Drug Carrier Equipment
-
Manufactured by Bluesail Medical Co., Ltdbased in CHINA
BioFreedom is a polymer- and carrier-free Drug Coated Stent with BA9™ (DCS). The combination of a selectively micro-structured abluminal surface (SMS) and Biolimus A9™ make BioFreedom a unique stent. At least 20% of PCI patients are High Bleeding Risk (HBR)1-9 requiring an individualized approach, BioFreedom provides a more ...
-
Manufactured by Merylo s.r.l.based in ITALY
MERYLO’ is developing a platform that will revolutionize the chemotherapeutic practice, proposing an innovative medical device that will work directly on the patients’ own blood at their bedside. By connecting our system to the patient circulatory system, it will be possible to entrap the chemotherapeutical agent into the patient’s Red Blood Cells (RBCs), thus producing a new ...
-
Manufactured by Concept Medical Inc.based in USA
Conversion of Sirolimus drug into sub-micron sized particles; Nanocarriers created by encapsulation of sub-micron sized Sirolimus drug into highly biocompatible drug Carrier-phospholipid; Upon inflation of MagicTouch SCB at target site, nanocarriers with Sirolimus drug inside gets transferred to the vessel wall ...
-
Manufactured by Concept Medical Inc.based in USA
Conversion of Sirolimus drug into sub-micron sized particles; Nanocarriers created by encapsulation of sub-micron sized Sirolimus drug into highly biocompatible drug Carrier-phospholipid; Encapsulated Sirolimus is coated on stent and parts of balloon; Upon implantation of Abluminus NP at target site, Nanocarriers with Sirolimus ...
-
Manufactured by Bluesail Medical Co., Ltdbased in CHINA
Innovative CHROMA stent platform with cobalt chromium alloy, Strut thickness only 84um, Classic rapamycin, Optimized drug dosage, Potential faster healing process without affecting restenosis rate, Unique formulated biodegradable polylactic acid(PLA) coating as drug carrier, which will degrade completely into CO2&H2O in 69 month with ...
-
based in GERMANY
Enhanced Hemostasis due to special patented surface treatment, Dry application adheres to bleeding site with enhanced blood absorption, Liquefies in 2 – 3 days so no need for removal for higher patient ...
-
based in GERMANY
Enhanced Hemostasis due to special patented surface treatment, Dry application of expanding sponge while quickly absorbing blood, Filling up space due to expansion upon uptake of blood, Liquefies in 2 – 3 days, so no need for ...
-
based in GERMANY
Available as block or cubes, High density sponge for prolonged support and scaffold function in graft and implant ...
-
Manufactured by Seppicbased in FRANCE
sensitive drugs. It swells in water without dissolving. ...
-
Manufactured by Concept Medical Inc.based in USA
Erectile dysfunction (ED) is de?ned as the recurrent inability to achieve and maintain an erection satisfactory for sexual ...
-
Manufactured by Yücel Medikal ve Tekstil Ürünleri San. Tic. Ltd. Sti.based in TURKEY
Clinisponge is produced from pharmaceutical purified gelatin. The sponge has an uniform porosity and reacts naturally to coagulation process. Due to its structure, blood platelets are caught and the coagulation cascade is activated; transforming soluble fibrinogen into a net of insoluble fibrin which stops the bleeding. Clinisponge is absorbed completely within 3-4 weeks when implanted into the ...
-
Manufactured by Ascendia Pharmaceuticalsbased in USA
AmorSol is a technology for the production of amorphous solid dispersions. Formulation of a drug substance in amorphous form greatly improves its solubility and dissolution kinetics, and has become a standard formulation technique in the pharmaceutical industry for reaching bioavailability goals for poorly water soluble ...
-
Manufactured by Concept Medical Inc.based in USA
A functioning dialysis access (AVF/AVG) is critical to the delivery of life saving hemodialysis therapy in patients with End Stage Renal Failure. PROMISING REVASCULARIZATION THERAPY FOR DYSFUNCTIONAL DIALYSIS FISTULA . MagicTouch AVF is intended for stenotic lesions of dysfunctional arteriovenous fistula and graft. ...
-
Manufactured by Concept Medical Inc.based in USA
AN EXCELLENT ALTERNATIVE FOR REVASCULAZATION OF SFA AND BTK ARTERIES.MagicTouch PTA is intended to prevent re-narrowing of superficial femoral and popliteal arteries in patients with peripheral artery ...
-
Manufactured by PolyActiva Pty Ltd.based in AUSTRALIA
For development of best-in-class ocular implants that deliver the right amount of drug, for the right period. Our technology is based on extensive scientific research leveraging our expertise in pharmaceutical, organic and polymer chemistry. The result is the creation of a unique method for precise and controlled drug delivery. Since many ...
-
Manufactured by Concept Medical Inc.based in USA
Novel, First of its kind Sirolimus drug coated balloon catheter for the treatment coronary artery disease. MagicTouch is intended for in-stent restenosis, small vessels, bifurcation lesions and de-novo lesions ...
-
Manufactured by Bluesail Medical Co., Ltdbased in CHINA
EXCEL is the first biodegradable polymer sirolimus eluting stent (BP-SES), being widely used in percutaneous coronary intervention (PCI) for patients with coronary atherosclerotic disease. A large number of evidence-based clinical data have demonstrated its safety and efficacy and more than a million patients have benefited since EXCEL launched in 2005. ...
-
Manufactured by Concept Medical Inc.based in USA
Drug is coated on the abluminal side only. Leading to mono directional drug release & less systemic exposure of drug which leads to faster ...
-
based in SWITZERLAND
Werner Schäfer, the founder of CIS Pharma, envisioned the synthesis of a bio-inspired polymer for tissue regeneration and site-specific drug delivery. We have generated a platform of proprietary polymers together with a toolkit to create biomaterials specific to their application and site of use. We are continuously expanding the ...
-
Manufactured by Concept Medical Inc.based in USA
ABLUMINUS DES+ designed by propriety ENVISOLUTION technology in a way that address the unmet clinical needs specially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease. ABLUMINUS DES+ Receives on-label indication for Diabetes Mellitus and Acute Myocardial infarction. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you